considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab chlorambucil is not co - Ofatumumab - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-12-04 16:10:34 Alkylating antineoplastic agents Nitrogen mustards Organochlorides Ofatumumab B-cell chronic lymphocytic leukemia Chlorambucil Fludarabine Leukemia Rituximab Chemistry Medicine Oncology		considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co Add to Reading List Source URL: www.pcodr.ca Download Document from Source Website File Size: 575,98 KB Share Document on Facebook

	PDF Document DocID: 17ueT - View Document
	Ifosfamide Chemotherapy Information: Ifosfamide Medication information leaflet for DocID: 11tyW - View Document
	improvement in survival compared to chlorambucil, it offers patients another choice in first-line treatment for CLL, and has a manageable toxicity profile. pERC deliberated on the potential cost-effectiveness of obinut DocID: MhUk - View Document
	considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co DocID: MhQS - View Document
	A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia David MacDonald, MD, FRCP(C);* Silvy Lachance, MD, FRCP(C), CSPQ;† Loree Larratt, MD, FRCP(C)‡ *Dr. David MacDonald, Assista DocID: Jstr - View Document